Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
778,585
-
Shares change
-
-16,343
-
Total reported value, excl. options
-
$44,573,000
-
Value change
-
-$935,612
-
Number of buys
-
1
-
Number of sells
-
-7
-
Price
-
$57.25
Significant Holders of NOVOZYMES A S DKK 2.0 - COM as of Q4 2020
8 filings reported holding B798FW902 - NOVOZYMES A S DKK 2.0 - COM as of Q4 2020.
NOVOZYMES A S DKK 2.0 - COM has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 778,585 shares
.
Largest 8 shareholders include Hemenway Trust Co LLC (206,884 shares), SOMERVILLE KURT F (201,293 shares), Broderick Brian C (103,399 shares), PUZO MICHAEL J (87,630 shares), Kidder Stephen W (82,525 shares), Page Arthur B (37,110 shares), Notis-McConarty Edward (32,876 shares), and Dempze Nancy E (26,868 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.